Members

Agendia NV


Member Type: Diagnostic Companies

Agendia is a world leader in gene expression analysis-based diagnostics. The company focuses on the development and commercialization of diagnostic tests using tumor gene expression profiling. Agendia was the first to commercialize a prognostic test - MammaPrint® - that predicts the chance of breast cancer recurrence. Recently Agendia also added CupPrint® to its pipeline for the identification of Cancers of Unknown Primary. Agendia maintains close ties with the Netherlands Cancer Institute (NKI), ensuring access to the latest developments in cancer research. Apart from the development of new cancer diagnostics, Agendia offers its expertise in finding new predictive gene expression profiles to companies focusing on new drug development in the area of oncology.

http://www.agendia.com/

Join Today

PMC members shape and advance the future of personalized medicine.
» Sign Up Today



Talk to Us

To learn more about PMC membership, contact PMC Director of Membership & Development Mary Bordoni.


Download a Member List